Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [1] Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains
    Molina-Infante, Javier
    Pazos-Pacheco, Carmen
    Vinagre-Rodriguez, Gema
    Perez-Gallardo, Belen
    Duenas-Sadornil, Carmen
    Hernandez-Alonso, Moises
    Gonzalez-Garcia, Guadalupe
    Mateos-Rodriguez, Jose M.
    Fernandez-Bermejo, Miguel
    Gisbert, Javier P.
    HELICOBACTER, 2012, 17 (04) : 269 - 276
  • [2] Sequential therapy versus standard triple therapy in Helicobacter pylori eradication in a high clarithromycin resistance setting
    Dolapcioglu, Can
    Koc-Yesiltoprak, Aysun
    Ahishali, Emel
    Kural, Aziz
    Dolapcioglu, Hatice
    Soylu, Aliye
    Dabak, Resat
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (08): : 2324 - 2328
  • [3] Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naive and retreat patients
    Abuhammour, Adnan
    Dajani, Asad
    Nounou, Mohammed
    Zakaria, Mohammed
    ARAB JOURNAL OF GASTROENTEROLOGY, 2016, 17 (03) : 131 - 136
  • [4] Clarithromycin-Resistant Genotypes and Eradication of Helicobacter Pylori
    Francavilla, Ruggiero
    Lionetti, Elena
    Castellaneta, Stefania
    Margiotta, Marcella
    Piscitelli, Domenico
    Lorenzo, Lorenzo
    Cavallo, Luciano
    Ierardi, Enzo
    JOURNAL OF PEDIATRICS, 2010, 157 (02) : 228 - 232
  • [5] Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication
    Chang, Ji Young
    Shim, Ki-Nam
    Tae, Chung Hyun
    Lee, Ko Eun
    Lee, Jihyun
    Lee, Kang Hoon
    Moon, Chang Mo
    Kim, Seong-Eun
    Jung, Hye-Kyung
    Jung, Sung-Ae
    BMC GASTROENTEROLOGY, 2017, 17
  • [6] Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori
    Polat, Zulfikar
    Kadayifci, Abdurrahman
    Kantarcioglu, Murat
    Ozcan, Ayhan
    Emer, Ozdes
    Uygun, Ahmet
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (02) : 165 - 168
  • [7] The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea
    Chung, Kwang Hyun
    Lee, Dong Ho
    Jin, Eunhyo
    Cho, Yuri
    Seo, Ji Yeon
    Kim, Nayoung
    Jeong, Sook Hyang
    Kim, Jin Wook
    Hwang, Jin-Hyeok
    Shin, Cheol Min
    GUT AND LIVER, 2014, 8 (06) : 605 - 611
  • [8] Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
    Eisig, Jaime Natan
    Navarro-Rodriguez, Tomas
    Sa Teixeira, Ana Cristina
    Silva, Fernando Marcuz
    Mattar, Rejane
    Chinzon, Decio
    Haro, Christiane
    Diniz, Marcio Augusto
    Moraes-Filho, Joaquim Prado
    Fass, Ronnie
    Barbuti, Ricardo Correa
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [9] Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    Hoshiya, S
    Watanabe, K
    Tokunaga, K
    Tanaka, A
    Ninomiya, H
    Shingaki, M
    Itoh, T
    Saito, S
    Ishida, H
    Takahashi, S
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) : 10 - 14
  • [10] Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
    Kate, Vikram
    Kalayarasan, Raja
    Ananthakrishnan, Nilakantan
    DRUGS, 2013, 73 (08) : 815 - 824